Financial Ratios ACS, Actividades de Construcción y Servicios, S.A.
Stocks
ACS
ES0167050915
Construction & Engineering
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.65 EUR | +0.44% |
|
+0.89% | +46.38% |
| 01/06 | AlphaValue/Baader Europe Upgrades ACS to Reduce Rating, Trims PT | MT |
| 26/05 | ACS's Turner to build cancer care facility in Manhattan, New York | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.81 | 0.47 | 1.29 | 1.33 | 2.08 | |||||
Return on Total Capital | 8.1 | 0.97 | 2.84 | 2.93 | 4.52 | |||||
Return On Equity % | -12.95 | 12.05 | 15.46 | 20.1 | 23.49 | |||||
Return on Common Equity | -18.28 | 10.15 | 14.34 | 16.48 | 19.95 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 31.74 | 30.49 | 31.58 | 32.06 | 31.3 | |||||
SG&A Margin | 22.41 | 21.57 | 21.92 | 22.3 | 20.09 | |||||
EBITDA Margin % | 9.08 | 2.13 | 3.16 | 3.47 | 4.23 | |||||
EBITA Margin % | 8.24 | 1.06 | 2.35 | 2.25 | 3.15 | |||||
EBIT Margin % | 7.99 | 0.82 | 2.14 | 2.01 | 2.91 | |||||
Income From Continuing Operations Margin % | -2.63 | 2.4 | 2.6 | 2.59 | 2.42 | |||||
Net Income Margin % | 10.94 | 1.99 | 2.18 | 1.99 | 1.91 | |||||
Net Avail. For Common Margin % | -3.24 | 1.79 | 2.18 | 1.99 | 1.91 | |||||
Normalized Net Income Margin | 3.74 | -0.02 | 1.49 | 0.11 | 0.85 | |||||
Levered Free Cash Flow Margin | -0.51 | 2.21 | 3.33 | 3.22 | 2.11 | |||||
Unlevered Free Cash Flow Margin | 0.1 | 2.89 | 4.31 | 4.27 | 3.03 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.76 | 0.92 | 0.96 | 1.06 | 1.14 | |||||
Fixed Assets Turnover | 16.31 | 21.59 | 20.8 | 17.61 | 18.44 | |||||
Receivables Turnover (Average Receivables) | 3.67 | 4.78 | 4.67 | 4.78 | 5.07 | |||||
Inventory Turnover (Average Inventory) | 26.08 | 29.74 | 30.21 | 31.19 | 36.1 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.43 | 1.28 | 1.2 | 1.17 | 1.16 | |||||
Quick Ratio | 1.2 | 0.96 | 1 | 1.03 | 1 | |||||
Operating Cash Flow to Current Liabilities | 0.01 | 0.09 | 0.08 | 0.12 | 0.12 | |||||
Days Sales Outstanding (Average Receivables) | 99.56 | 76.38 | 78.15 | 76.59 | 72.05 | |||||
Days Outstanding Inventory (Average Inventory) | 14 | 12.27 | 12.08 | 11.73 | 10.11 | |||||
Average Days Payable Outstanding | 139.65 | 101.68 | 107.48 | 106.76 | 102.39 | |||||
Cash Conversion Cycle (Average Days) | -26.09 | -13.02 | -17.24 | -18.43 | -20.23 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 157.62 | 173.82 | 187.9 | 280.3 | 298.54 | |||||
Total Debt / Total Capital | 61.18 | 63.48 | 65.27 | 73.7 | 74.91 | |||||
LT Debt/Equity | 129.75 | 147.89 | 157.08 | 218.61 | 232.5 | |||||
Long-Term Debt / Total Capital | 50.36 | 54.01 | 54.56 | 57.48 | 58.34 | |||||
Total Liabilities / Total Assets | 80.29 | 83.03 | 84.57 | 87.83 | 88.55 | |||||
EBIT / Interest Expense | 8.28 | 0.77 | 1.37 | 1.2 | 1.99 | |||||
EBITDA / Interest Expense | 10.06 | 2.49 | 2.36 | 2.44 | 3.32 | |||||
(EBITDA - Capex) / Interest Expense | 8.62 | 1.7 | 1.47 | 1.5 | 2.3 | |||||
Total Debt / EBITDA | 4.1 | 12.34 | 8.03 | 8.43 | 6.39 | |||||
Net Debt / EBITDA | -0.45 | 0.74 | 0.4 | 1.17 | 0.92 | |||||
Total Debt / (EBITDA - Capex) | 4.78 | 18.09 | 12.88 | 13.77 | 9.22 | |||||
Net Debt / (EBITDA - Capex) | -0.52 | 1.09 | 0.65 | 1.92 | 1.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -5.01 | 20.76 | 6.32 | 16.5 | 19.75 | |||||
Gross Profit, 1 Yr. Growth % | 0.38 | 16 | 10.1 | 18.28 | 16.91 | |||||
EBITDA, 1 Yr. Growth % | 22.77 | -16.72 | 58.19 | 28.58 | 46.04 | |||||
EBITA, 1 Yr. Growth % | 43.26 | -42.96 | 136.17 | 12.32 | 68.03 | |||||
EBIT, 1 Yr. Growth % | 48.87 | -50.02 | 176.46 | 10.05 | 73.57 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -212.72 | -210.33 | 14.95 | 16.34 | 11.95 | |||||
Net Income, 1 Yr. Growth % | 430.56 | -78.06 | 16.75 | 6.08 | 14.83 | |||||
Normalized Net Income, 1 Yr. Growth % | 56.65 | -19.53 | -7.63T | -91.26 | 813.99 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -383.93 | -171.01 | 32.71 | 7.78 | 14.24 | |||||
Accounts Receivable, 1 Yr. Growth % | -21.34 | 10.42 | 7.28 | 20 | 7.08 | |||||
Inventory, 1 Yr. Growth % | 3.75 | 11.71 | -4.7 | 29.57 | -14.63 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -30.02 | 21.61 | 1.05 | 73.87 | -19.89 | |||||
Total Assets, 1 Yr. Growth % | -4.47 | 5.37 | -2.88 | 15.14 | 7.53 | |||||
Tangible Book Value, 1 Yr. Growth % | -2.44T | -25.91 | -9.53 | -142.91 | 23.01 | |||||
Common Equity, 1 Yr. Growth % | 79.52 | -12.42 | -3.93 | -11.54 | 2.14 | |||||
Cash From Operations, 1 Yr. Growth % | -82.21 | 758.19 | -13.82 | 85.9 | 9.09 | |||||
Capital Expenditures, 1 Yr. Growth % | -55.94 | -26.16 | 73.76 | 33.36 | 12.55 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -140.58 | -162.83 | 59.88 | 12.91 | -21.51 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -94.66 | -195.41 | 58.67 | 15.57 | -15.07 | |||||
Dividend Per Share, 1 Yr. Growth % | 6.27 | 0.6 | 0 | -0.05 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -15.57 | 7.1 | 13.31 | 11.29 | 18.11 | |||||
Gross Profit, 2 Yr. CAGR % | -18.54 | 7.91 | 13.01 | 14.12 | 17.6 | |||||
EBITDA, 2 Yr. CAGR % | 7.42 | -41.08 | 14.78 | 42.2 | 37.03 | |||||
EBITA, 2 Yr. CAGR % | 16.96 | -52.87 | 16.07 | 62.22 | 37.38 | |||||
EBIT, 2 Yr. CAGR % | 18.77 | -56.93 | 17.55 | 73.66 | 38.21 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -33.81 | 11.52 | 12.61 | 15.64 | 14.12 | |||||
Net Income, 2 Yr. CAGR % | 77.92 | 7.9 | -49.39 | 11.29 | 10.37 | |||||
Normalized Net Income, 2 Yr. CAGR % | 26.85 | -89.7 | 678.2 | 156.43 | -10.67 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -9.82 | 42 | -2.92 | 19.6 | 10.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | -20.16 | -6.8 | 8.84 | 13.46 | 13.36 | |||||
Inventory, 2 Yr. CAGR % | -10.01 | 7.66 | 3.18 | 11.12 | 5.17 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -28.26 | -7.75 | 10.86 | 32.55 | 18.02 | |||||
Total Assets, 2 Yr. CAGR % | -5.21 | 0.33 | 1.16 | 5.75 | 11.27 | |||||
Tangible Book Value, 2 Yr. CAGR % | 258.47 | 316.15 | -18.12 | -37.69 | -27.35 | |||||
Common Equity, 2 Yr. CAGR % | 19.7 | 25.39 | -8.27 | -7.82 | -4.95 | |||||
Cash From Operations, 2 Yr. CAGR % | -67.25 | 23.57 | 171.95 | 26.57 | 42.41 | |||||
Capital Expenditures, 2 Yr. CAGR % | -42.42 | -42.96 | 13.27 | 52.23 | 22.51 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -61.52 | 46.24 | 0.23 | 34.26 | -5.86 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -84.76 | 39.2 | 23.04 | 35.34 | -0.93 | |||||
Dividend Per Share, 2 Yr. CAGR % | -9.45 | 3.4 | 0.3 | -0.02 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -8.75 | -4.88 | 6.84 | 14.36 | 14.04 | |||||
Gross Profit, 3 Yr. CAGR % | -11.34 | -8.35 | 8.63 | 14.74 | 15.04 | |||||
EBITDA, 3 Yr. CAGR % | 4.48 | -31.15 | -18.11 | 18.97 | 43.47 | |||||
EBITA, 3 Yr. CAGR % | 9.48 | -40.36 | -19.35 | 14.5 | 64.13 | |||||
EBIT, 3 Yr. CAGR % | 10.61 | -43.99 | -19.96 | 14.66 | 73.63 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -16.59 | -21.52 | 12.65 | 13.84 | 14.4 | |||||
Net Income, 3 Yr. CAGR % | 49.27 | -11.44 | 10.77 | -35.23 | 12.46 | |||||
Normalized Net Income, 3 Yr. CAGR % | 16.94 | -77.83 | -7.23 | 74.26 | 291.6 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.65 | -16.72 | 38.83 | 0.52 | 17.78 | |||||
Accounts Receivable, 3 Yr. CAGR % | -9.56 | -11.05 | -2.33 | 12.44 | 11.3 | |||||
Inventory, 3 Yr. CAGR % | -5.04 | -3.28 | 3.37 | 11.32 | 1.77 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -18.29 | -14.46 | -4.9 | 28.8 | 12.07 | |||||
Total Assets, 3 Yr. CAGR % | -0.03 | -1.81 | -0.75 | 5.62 | 6.34 | |||||
Tangible Book Value, 3 Yr. CAGR % | 113.61 | 111.95 | 150.23 | -33.99 | -21.84 | |||||
Common Equity, 3 Yr. CAGR % | 13.31 | 7.86 | 14.74 | -9.38 | -4.61 | |||||
Cash From Operations, 3 Yr. CAGR % | -55.61 | -2.72 | 9.58 | 139.56 | 20.45 | |||||
Capital Expenditures, 3 Yr. CAGR % | -21.86 | -37.44 | -17.31 | 19.61 | 37.65 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -64.02 | -7.93 | 50.65 | 4.24 | 12.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -79.75 | -5.54 | 45.41 | 20.45 | 15.87 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.9 | -6.21 | 2.25 | 0.18 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.73 | -0.74 | -0.5 | 1.29 | 11.21 | |||||
Gross Profit, 5 Yr. CAGR % | -3.67 | -3.36 | -2.3 | 0.05 | 12.13 | |||||
EBITDA, 5 Yr. CAGR % | 6.09 | -19.58 | -12.59 | -7.98 | 0.5 | |||||
EBITA, 5 Yr. CAGR % | 10.89 | -26.45 | -13.63 | -11.01 | -0.36 | |||||
EBIT, 5 Yr. CAGR % | 10.22 | -28.8 | -14.16 | -11.92 | -0.59 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 4.2 | -5.77 | -5.95 | -8.35 | 13.24 | |||||
Net Income, 5 Yr. CAGR % | 32.31 | -3.58 | -3.15 | -2.97 | 10.61 | |||||
Normalized Net Income, 5 Yr. CAGR % | 23.61 | -60.08 | -4.01 | -40.98 | -8.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 23.76 | -2.55 | 0.38 | -3.75 | 26.93 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.71 | -4.35 | -2.6 | -1.95 | 3.67 | |||||
Inventory, 5 Yr. CAGR % | -12.01 | -4.07 | -1.83 | 2.24 | 4.09 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -6.59 | -0.54 | -7.68 | 1.92 | 3.68 | |||||
Total Assets, 5 Yr. CAGR % | 1.32 | 3.7 | 0.44 | 1.15 | 3.89 | |||||
Tangible Book Value, 5 Yr. CAGR % | 34.58 | 42.19 | 45.56 | 29.88 | 52.58 | |||||
Common Equity, 5 Yr. CAGR % | 12.12 | 8.19 | 4.12 | 1.29 | 6.42 | |||||
Cash From Operations, 5 Yr. CAGR % | -32.06 | -1.32 | -8.34 | 8.08 | 21.69 | |||||
Capital Expenditures, 5 Yr. CAGR % | -8.05 | -14.81 | -9.35 | -10.72 | -3.23 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -34.13 | 37.63 | -17.06 | 7.06 | 24.79 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -54.48 | 21.88 | -13.71 | 9.07 | 24.69 | |||||
Dividend Per Share, 5 Yr. CAGR % | 10.83 | 7.75 | 1.26 | -3.79 | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















